Remission and Lupus Low Disease Activity State Attainment and Glucocorticoid Reduction without Increasing Flares with Anifrolumab in Asian patients with Systemic Lupus Erythematosus: A Post Hoc Analysis from a Phase III Study (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2222; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • P3 data • Retrospective data • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
|